Oracle (ORCL) Stock Forecast & Price Target

$148.68 -3.78 (-2.48%)

Closing price 06/26/2026 04:00 PM Eastern

Extended Trading

$149.02 +0.34 (+0.23%)

As of 06/26/2026 08:00 PM Eastern

Compare

Oracle - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy

Based on 38 Analyst Ratings

Sell
1

Hold
7

Buy
30

Based on 38 Wall Street analysts who have issued ratings for Oracle in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 38 analysts, 1 has given a sell rating, 7 have given a hold rating, 28 have given a buy rating, and 2 have given a strong buy rating for ORCL.

Consensus Price Target

$268.27
80.43% Upside

According to the 38 analysts' twelve-month price targets for Oracle, the average price target is $268.27. The highest price target for ORCL is $400.00, while the lowest price target for ORCL is $160.00. The average price target represents a forecasted upside of 80.43% from the current price of $148.68.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for ORCL and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Oracle and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ORCL Analyst Ratings Over Time

Type	Current Forecast 6/27/25 to 6/27/26	1 Month Ago 5/28/25 to 5/28/26	3 Months Ago 3/29/25 to 3/29/26	1 Year Ago 6/27/24 to 6/27/25
Strong Buy	2 Strong Buy rating(s)	3 Strong Buy rating(s)	3 Strong Buy rating(s)	2 Strong Buy rating(s)
Buy	28 Buy rating(s)	29 Buy rating(s)	27 Buy rating(s)	19 Buy rating(s)
Hold	7 Hold rating(s)	9 Hold rating(s)	9 Hold rating(s)	10 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$268.27	$261.46	$262.91	$197.67
Forecasted Upside	80.43% Upside	28.53% Upside	87.94% Upside	-5.95% Downside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

ORCL Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

ORCL Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Oracle Stock vs. The Competition

Type	Oracle	Computer and Technology Companies	Broader Market
Consensus Rating Score	2.82	2.29	2.52
Consensus Rating	Moderate Buy	Hold	Moderate Buy
Predicted Upside	80.43% Upside	189.99% Upside	14.32% Upside
News Sentiment Rating	Positive News See Recent ORCL News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
6/11/2026	KeyCorp 2 of 5 stars		Reiterated Rating	Overweight
6/11/2026	Wedbush 5 of 5 stars	Daniel Ives 3 of 5 stars	Lower Target	Outperform	$275.00 ➝ $240.00	+33.18%
6/11/2026	Sanford C. Bernstein 4 of 5 stars	Mark Moerdler Not Rated	Boost Target	Outperform	$319.00 ➝ $325.00	+80.35%
6/11/2026	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Pat Colville Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Overweight
6/11/2026	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Outperform	$225.00	+11.92%
6/11/2026	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Tyler Radke Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Market Outperform
6/11/2026	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keith Weiss Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Mixed
6/11/2026	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Raimo Lenschow Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$240.00 ➝ $250.00	+24.35%
6/11/2026	Moffett Nathanson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target		$325.00	+61.66%
6/11/2026	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rishi Jaluria Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Sector Perform	$190.00	+6.09%
Read now. Do not delete. You’ve been warned. (Ad) Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” Porter Stansberry exposes how the convergence of three immense forces is about to rewrite everything about the American way of life: how you work, save, invest… it’s all about to change. Don’t be left behind. Click here now.
6/11/2026	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Thomas Blakey Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Overweight	$284.00	+58.85%
6/11/2026	Stephens Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brett Huff Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Equal Weight	$164.00	-7.38%
6/11/2026	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Gil Luria Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$200.00 ➝ $225.00	+11.92%
6/11/2026	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John DiFucci Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$400.00	+98.96%
6/11/2026	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Keith Bachman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$200.00 ➝ $220.00	+9.43%
6/11/2026	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Billy Fitzsimmons Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$210.00 ➝ $225.00	+11.92%
6/9/2026	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brad Sills Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$200.00 ➝ $240.00	+13.39%
6/8/2026	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Derrick Wood Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$250.00 ➝ $300.00	+42.48%
6/8/2026	Oppenheimer Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brian Schwartz Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Outperform	$235.00 ➝ $275.00	+28.86%
6/8/2026	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Outperform	$245.00	+14.80%
6/5/2026	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Difucci Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$400.00	+69.12%
6/3/2026	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Siti Panigrahi Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target		$320.00	+30.72%
6/2/2026	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Karl Keirstead Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$250.00 ➝ $285.00	+16.41%
5/29/2026	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Upgrade	Hold (C) ➝ Hold (C+)
5/7/2026	Arete Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target	Neutral ➝ Buy	$255.00	+31.31%
3/11/2026	Monness Crespi & Hardt Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Neutral ➝ Hold
3/11/2026	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brad Reback Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$275.00 ➝ $220.00	+33.49%
3/11/2026	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Murphy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Neutral ➝ Overweight	$230.00 ➝ $210.00	+40.36%
3/10/2026	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Rob Oliver Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Outperform	$300.00 ➝ $200.00	+31.98%
3/9/2026	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brad Zelnick Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$375.00 ➝ $300.00	+102.48%
3/5/2026	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brent Thill Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Buy	$400.00 ➝ $320.00	+106.62%
2/9/2026	Melius Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ben Reitzes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target		$160.00	+2.82%
2/5/2026	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Walravens Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Market Outperform	$342.00 ➝ $285.00	+94.21%
1/12/2026	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Kash Rangan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Strong-Buy
12/3/2025	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Initiated Coverage	Equal Weight ➝ Overweight	$280.00	+39.15%
11/26/2025	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Stephen Bersey Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$382.00	+85.95%
11/10/2025	Erste Group Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Buy ➝ Hold
10/17/2025	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Outperform
9/25/2025	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Alex Haissl Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target		$175.00	-41.03%
9/15/2025	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Nay Soe Naing Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Hold	$202.00 ➝ $306.00	+1.24%
Stranded On The Flood Plains of History (Ad) The petrodollar arrangement that Kissinger brokered in 1974 officially expired in June 2024. China has slashed U.S. Treasury holdings by 45% from peak, and central banks are swapping dollars for gold at the fastest pace since the Cold War. Porter Stansberry believes Trump is channeling more than $3 trillion toward securing the minerals, chips, and infrastructure that make AI possible - and companies at those chokepoints like Vertiv (up 500%), GE Vernova (up 700%), and Arista Networks (up 750%) are already moving. Porter's new briefing names one asset to buy today plus five stocks positioned at the narrowest chokepoints of what he calls the Silicon Dollar. Read Porter's full briefing and get the ticker names today
9/10/2025	BNP Paribas Exane Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Set Target		$377.00	+14.80%
6/18/2025	Roth Mkm Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Hold
6/18/2025	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Strong-Buy
6/12/2025	Westpark Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Curtis Shauger Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Buy	$195.00 ➝ $246.00	+39.51%
6/10/2025	Loop Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Mark Murphy Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target		$135.00	-23.99%
6/9/2025	Canadian Imperial Bank of Commerce Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 07:49 AM ET.

Should I Buy Oracle Stock? ORCL Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, June 24, 2026. Please send any questions or comments about these Oracle pros and cons to contact@marketbeat.com.

Oracle
Bull Case

Here are some ways that investors could benefit from investing in Oracle:

Oracle's recent quarterly revenue growth of over 20% year-over-year indicates strong demand for its products, particularly in cloud and AI sectors, which could lead to sustained profitability.
The company has a solid earnings per share (EPS) guidance for Q1 2027, suggesting confidence in future performance, with estimates around 1.720-1.760 EPS.
Oracle's current stock price is approximately $176, which some analysts believe may be undervalued given the company's strong backlog and growth potential in AI infrastructure.
Recent partnerships, such as the expansion with Baystate Health, highlight Oracle's commitment to enhancing its healthcare software offerings, which could drive future revenue growth.
With a dividend yield of about 1.1% and a payout ratio of 34.31%, Oracle provides a steady income stream for investors while maintaining a healthy balance for reinvestment in growth initiatives.

Oracle
Bear Case

Investors should be bearish about investing in Oracle for these reasons:

Despite strong revenue growth, Oracle's stock has experienced significant volatility, with recent sell-offs raising concerns about market sentiment and potential overvaluation.
Analysts are divided on Oracle's long-term prospects, with some citing heavy spending on AI and restructuring costs as potential risks that could impact profitability.
Insider selling, such as the recent sale of 15,000 shares by an executive vice president, may signal a lack of confidence in the stock's short-term performance.
While Oracle's cloud and AI demand is strong, the competitive landscape in these sectors is fierce, and maintaining market share could be challenging.
Concerns about the company's debt levels and the impact of ongoing investments in technology could weigh on future earnings and stock performance.

ORCL Forecast - Frequently Asked Questions

According to the research reports of 38 Wall Street equities research analysts, the average twelve-month stock price forecast for Oracle is $268.27, with a high forecast of $400.00 and a low forecast of $160.00.

38 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Oracle in the last twelve months. There is currently 1 sell rating, 7 hold ratings, 28 buy ratings and 2 strong buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" ORCL shares.

According to analysts, Oracle's stock has a predicted upside of 80.43% based on their 12-month stock forecasts.

Over the previous 90 days, Oracle's stock had 1 upgrade by analysts.

Oracle has been rated by research analysts at Arete Research, Bank of America, Barclays, BMO Capital Markets, BTIG Research, Cantor Fitzgerald, Citigroup, DA Davidson, Evercore, Guggenheim, KeyCorp, Mizuho, Moffett Nathanson, Morgan Stanley, Oppenheimer, Piper Sandler, Royal Bank Of Canada, Sanford C. Bernstein, Scotiabank, Stephens, TD Cowen, UBS Group, Wedbush, Weiss Ratings, and Wolfe Research in the past 90 days.

Analysts like Oracle more than other "computer and technology" companies. The consensus rating for Oracle is Moderate Buy while the average consensus rating for "computer and technology" companies is Hold. Learn more on how ORCL compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Oracle Recommendations

This page (NYSE:ORCL) was last updated on 6/27/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Oracle (ORCL) Stock Forecast & Price Target